Physicians and scientists at UC San Diego Health have launched a pair of serological tests that will look for novel coronavirus antibodies—evidence in persons tested that they have previously been infected by the viral cause of COVID-19, even if they never experienced tell-tale symptoms.
The National Institutes of Health has renewed its commitment to the Adolescent Brain Cognitive Development (ABCD) Study, the largest long-term study of brain development and child health ever conducted in the United States. The awards to UC San Diego total just over $60 million.
In this time of fear and uncertainty, many seek to understand how the novel coronavirus will change the world permanently.
Companies that found their footing at the Qualcomm Institute Innovation Space are working to model disease outbreaks, increase access to offline education and facilitate research on COVID-19
Measures to slow the spread of the coronavirus have reduced the demand for fuel and slashed oil prices. Global emissions of carbon dioxide (CO2), the chief long-term cause of climate warming, have slid perhaps by one-fifth, but can we expect COVID-19 to create lasting change for the planet?
UC San Diego researchers recently created a pharmacophore model and conducted data mining of the conformational database of FDA-approved drugs that identifies 64 compounds as potential inhibitors of the COVID-19 protease.
Keep up with all the latest from UC San Diego. Subscribe to the newsletter today.
